Sunyoung Kim, CEO, and William K. Schmidt, senior vice president, Clinical Development, Helixmith Co, Ltd, discuss a non-viral plasmid DNA-based medicine that, when injected into muscles, stimulates the synthesis of twin proteins that are, in...
Sunyoung Kim, CEO, and William K. Schmidt, senior vice president, Clinical Development, Helixmith Co, Ltd, discuss a non-viral plasmid DNA-based medicine that, when injected into muscles, stimulates the synthesis of twin proteins that are, in...
Sunyoung Kim, CEO, and William...